Skip to main content
. 2021 Sep 8;19(6):884–892. doi: 10.20892/j.issn.2095-3941.2020.0598

Table 3.

Prognostic factors for overall survival of all patients in propensity-score matched cohorts after treatment

Covariate Comparison Univariate analysis
Multivariate analysis
χ 2 P value χ 2 P value
Age, years < 65 vs. ≥ 65 2.425 0.028* 1.03 0.14
Sex Male vs. female 1.828 0.545
RPA 1 vs. 2 3.289 0.005** 2.219 0.01*
KPS < 80 vs. > 70 0.449 0.012* 0.511 0.457
No of lesions 2 vs. > 2 0.479 0.122
Primary cancer Lung vs. other 1.14 0.71
Lung vs. breast 0.695 0.417
Prior WBRT Yes vs. no 1.227 0.53
Neurologic symptoms Yes vs. no 1.543 0.27
Extracranial metastasis Yes vs. no 1.442 0.253
Time to BM, months < 12 months vs. ≥ 12 months 2.312 0.008** 1.005 0.476

*P < 0.05; **P < 0.01.